Arcus Biosciences
Utility Patents

Last updated:

List of all Arcus Biosciences patents 8 in total

Status Patent
Grant
Utility: Inhibitors of CD73-mediated immunosuppression External link
Filling date: 6 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders External link
Filling date: 6 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Azolopyrimidine for the treatment of cancer-related disorders External link
Filling date: 6 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Inhibitors of adenosine 5'-nucleotidase External link
Filling date: 6 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Quinazoline-pyridine derivatives for the treatment of cancer-related disorders External link
Filling date: 6 Sep 2025 Issue date: 29 Jun 2021
Grant
Utility: Modulators of 5'-nucleotidase, ecto and the use thereof External link
Filling date: 6 Sep 2025 Issue date: 11 May 2021
Grant
Utility: Modulators of 5'-nucleotidase, ecto and the use thereof External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Azolopyrimidine for the treatment of cancer-related disorders External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2019

Showing 1 to 8 of 8 patents.